Aprinoia Therapeutics Inc. Mediaroom - PR Newswire APAC

Search

Aprinoia Therapeutics Inc.

Latest News

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease

TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initi...

2019-11-21 23:00 1401

APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research

TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology compan...

2019-05-23 20:00 2930